Page 294 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 294
Fatty Liver Disease: Clinical (Cont.)
P0996 THE EFFECTS OF SHORT-TERM EXENATIDE ON
CIRCULATING ADIPONECTIN LEVELS IN PATIENTS
WITH TYPE 2 DIABETES MELLITUS (DMT2) WITH OR
WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE
(NAFLD): A RANDOMIZED, OPEN-LABEL, CONTROLLED
INTERVENTION TRIAL
Savvoula Savvidou*, Kyparissia Karatzidou, Asterios Gagalis,
Kalliopi Tsakiri, Prodromos Hytiroglou, John Goulis, Greece
P0997 WFA+-M2BP IS A PREDICTIVE FACTOR FOR FIBROSIS
PROGRESSION IN NAFLD
Tomoaki Nakajima*, Itaru Ozeki, Shuhei Hige,Yoshiyasu Karino,
Joji Toyota, Japan
P0998 EVALUATION OF CIRCULATING PROGENITOR CELLS
LEVELS AND FUNCTIONAL CAPACITY IN PATIENTS WITH
ePOSTERS NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Elzafir Elsheikh, Zahra Younoszai, Munkhzul Otgonsuren,
Thomas Jeffers, Hussain Allawi, Brian Marsiglia, David Chapman,
Sharon L. Hunt, Brian P. Lam, Zobair Younossi*, The United States
P0999 SERUM VITAMIN D DEFICIENCY IN NON-ALCOHOLIC
FATTY LIVER DISEASE; CHICKEN OR THE EGG?
Dae Won Jun*, Waqar K. Saeed, Ho Hyun Nam, South Korea
P1000 PREVALENCE AND PREDICTORS OF TRANSIENT
ELASTOGRAPHY-DEFINED NON-ALCOHOLIC FATTY
LIVER DISEASE WITH AND WITHOUT SIGNIFICANT
LIVER FIBROSIS AMONG ASYMPTOMATIC SUBJECTS
UNDERGOING A MEDICAL HEALTH CHECK-UP
Hye Won Lee*, Seung Up Kim, Beom Kyung Kim, Jun Yong Park,
Do Young Kim, Sang Hoon Ahn, Ki Jun Song, Kwang-Hyub Han,
South Korea
P1001 CAROTID-FEMORAL PULSE WAVE VELOCITY (CF-PWV) AS
A SURROGATE MARKER OF ADVANCED LIVER FIBROSIS
IN TYPE-2 DIABETIC (T2DM) PATIENTS EVALUATED BY
TRANSIENT HEPATIC ELASTOGRAPHY
Nathalie C. Leite*, Marcel T. Ferreira, Gil Salles, Claudia R. Cardoso,
Cristiane A. Villela-Nogueira, Brazil
294 The International Liver Congress™ 2015 • ILC Programme
P0996 THE EFFECTS OF SHORT-TERM EXENATIDE ON
CIRCULATING ADIPONECTIN LEVELS IN PATIENTS
WITH TYPE 2 DIABETES MELLITUS (DMT2) WITH OR
WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE
(NAFLD): A RANDOMIZED, OPEN-LABEL, CONTROLLED
INTERVENTION TRIAL
Savvoula Savvidou*, Kyparissia Karatzidou, Asterios Gagalis,
Kalliopi Tsakiri, Prodromos Hytiroglou, John Goulis, Greece
P0997 WFA+-M2BP IS A PREDICTIVE FACTOR FOR FIBROSIS
PROGRESSION IN NAFLD
Tomoaki Nakajima*, Itaru Ozeki, Shuhei Hige,Yoshiyasu Karino,
Joji Toyota, Japan
P0998 EVALUATION OF CIRCULATING PROGENITOR CELLS
LEVELS AND FUNCTIONAL CAPACITY IN PATIENTS WITH
ePOSTERS NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Elzafir Elsheikh, Zahra Younoszai, Munkhzul Otgonsuren,
Thomas Jeffers, Hussain Allawi, Brian Marsiglia, David Chapman,
Sharon L. Hunt, Brian P. Lam, Zobair Younossi*, The United States
P0999 SERUM VITAMIN D DEFICIENCY IN NON-ALCOHOLIC
FATTY LIVER DISEASE; CHICKEN OR THE EGG?
Dae Won Jun*, Waqar K. Saeed, Ho Hyun Nam, South Korea
P1000 PREVALENCE AND PREDICTORS OF TRANSIENT
ELASTOGRAPHY-DEFINED NON-ALCOHOLIC FATTY
LIVER DISEASE WITH AND WITHOUT SIGNIFICANT
LIVER FIBROSIS AMONG ASYMPTOMATIC SUBJECTS
UNDERGOING A MEDICAL HEALTH CHECK-UP
Hye Won Lee*, Seung Up Kim, Beom Kyung Kim, Jun Yong Park,
Do Young Kim, Sang Hoon Ahn, Ki Jun Song, Kwang-Hyub Han,
South Korea
P1001 CAROTID-FEMORAL PULSE WAVE VELOCITY (CF-PWV) AS
A SURROGATE MARKER OF ADVANCED LIVER FIBROSIS
IN TYPE-2 DIABETIC (T2DM) PATIENTS EVALUATED BY
TRANSIENT HEPATIC ELASTOGRAPHY
Nathalie C. Leite*, Marcel T. Ferreira, Gil Salles, Claudia R. Cardoso,
Cristiane A. Villela-Nogueira, Brazil
294 The International Liver Congress™ 2015 • ILC Programme